This is some extra info about IntelGenx (OTCQX:IGXT) which I wrote about in my article Rapidly Rising Biotech, Pharmaceutical Companies with Big Potential.
IntelGenx is a drug delivery company focused on the development of oral controlled-release products as well as novel rapidly disintegrating delivery systems. The company uses its unique multiple layer delivery system to provide zero-order release of active drugs in the gastrointestinal tract. IntelGenx has also developed novel delivery technologies for the rapid delivery of pharmaceutically active substances in the oral cavity based on its experience with rapidly disintegrating films.
The company has no-debt, has a cash burn of $2 million per year, and has cash till 2013 without considering upfront payment from upcoming Partnership and without sales from CPI-300, which is expecting approval in December.
Disclosure: I have no positions in any stocks mentioned, and no plans to initiate any positions within the next 72 hours.